Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Cellares is seeking an Automation Engineer to drive development and operation of automated QC workflows in the Cell Q system at its South San Francisco site. You will design liquid handling protocols, program GBG code, and validate methods before transfer.
Collaborate with Analytical Development, Quality Control, Software, Manufacturing and IT to document methods, train users, and manage automated test methods from development through validation.
We are seeking an Automation Engineer to drive and support the development, platforming and day-to-day operation of automated QC workflows in our Cell Q system at our South San Francisco, CA site. This role is central to translating newly developed assays into scalable, automated workflows ahead of transfer and validation on Cell Q.
The successful candidate will work hands-on to develop and program liquid handling methods, write and maintain Biosero Green Button Go (GBG) code, and test these methods to confirm functionality and performance before they move into validation. Working closely with Analytical Development, Quality Control, Software, Manufacturing and IT, the Automation Engineer will contribute to development, user training, technical documentation and controlled management of automated test methods.
Candidates should enjoy working in a fast-paced, mission-driven environment and be comfortable owning assay automation from early-stage development through hand-off for validation.
$90,000 - $210,000 a year
Cellares total compensation package contains
All displayed pay ranges are approximate, negotiable, and location dependent.
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.